Welcome to LookChem.com Sign In|Join Free

CAS

  • or
nafenopin-coenzyme A is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

112195-81-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 112195-81-0 Structure
  • Basic information

    1. Product Name: nafenopin-coenzyme A
    2. Synonyms: nafenopin-coenzyme A
    3. CAS NO:112195-81-0
    4. Molecular Formula: C41H56N7O18P3S
    5. Molecular Weight: 1059.905723
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 112195-81-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: °Cat760mmHg
    3. Flash Point: °C
    4. Appearance: /
    5. Density: 1.65g/cm3
    6. Refractive Index: 1.691
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: nafenopin-coenzyme A(CAS DataBase Reference)
    10. NIST Chemistry Reference: nafenopin-coenzyme A(112195-81-0)
    11. EPA Substance Registry System: nafenopin-coenzyme A(112195-81-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 112195-81-0(Hazardous Substances Data)

112195-81-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 112195-81-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,1,9 and 5 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 112195-81:
(8*1)+(7*1)+(6*2)+(5*1)+(4*9)+(3*5)+(2*8)+(1*1)=100
100 % 10 = 0
So 112195-81-0 is a valid CAS Registry Number.
InChI:InChI=1/C41H56N7O18P3S/c1-40(2,21-62-69(59,60)66-68(57,58)61-20-29-33(65-67(54,55)56)32(50)38(63-29)48-23-47-31-35(42)45-22-46-36(31)48)34(51)37(52)44-17-16-30(49)43-18-19-70-39(53)41(3,4)64-26-14-12-25(13-15-26)28-11-7-9-24-8-5-6-10-27(24)28/h5-6,8,10,12-15,22-23,28-29,32-34,38,50-51H,7,9,11,16-21H2,1-4H3,(H,43,49)(H,44,52)(H,57,58)(H,59,60)(H2,42,45,46)(H2,54,55,56)/t28?,29-,32-,33-,34+,38-/m1/s1

112195-81-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phe

1.2 Other means of identification

Product number -
Other names Nafenopin-coenzyme A

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:112195-81-0 SDS

112195-81-0Downstream Products

112195-81-0Relevant articles and documents

Kinetic Characteristics of Rat Liver Peroxisomal Nafenopin-CoA Ligase

Roberts, Benjamin J.,Macleod, John K.,Singh, Inderjit,Knights, Kathleen M.

, p. 1335 - 1340 (2007/10/03)

In this study we have demostrated that rat hepatic peroxisomes catalyse the formation of nafenopin-CoA. The process is mediated by apparent high affinity (Km 6.7 μM), low capacity (Vmax 0.31 nmol/mg/min) and low affinity, high capacity isoforms. Palmitic acid (Ki 1.1 μM), R(-) ibuprofen (Ki 7.9 μM), ciprofibrate (Ki 60.2 μM) and clofibric acid (Ki 86,8 μM) competitively inhibited nafenopin-CoA formation catalysed by the apparent high affinity isoform. An antibody raised against the microsomal palmitoyl-CoA ligase inhibited the equivalent peroxisomal enzyme significantly (P 0.001) but did not inhibit peroxisomal nafenopin-CoA ligase activity. These data suggest that nafenopin-CoA formation is catalysed by a peroxisomal CoA ligase which differs from the peroxisomal long chain fatty acid-CoA ligase in relation to its xenobiotic/antibody inhibitor profile and kinetic characteristics.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 112195-81-0